speb/financial-data huggingface dataset:
PHM7.DE balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1071000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Normalized EBITDA: 12757000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Normalized Income: 9358076438.72
PHM7.DE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 8753000000.00
PHM7.DE cash_flow (annual, 2024-12-31) — Operating Gains Losses: -3352000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Operating Income: 11630000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Operating Revenue: 24018000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1690651867.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Other Current Assets: 129000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 1527000000.00
PHM7.DE balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 1527000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -2400000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Other Income Expense: 3065000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 12973000000.00
PHM7.DE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 53000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 934000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 365000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 102000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 28000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Payables: 2432000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 7254000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Pretax Income: 13658000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Properties: 0.00
PHM7.DE balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
PHM7.DE cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
PHM7.DE cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Raw Materials: 781000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Receivables: 177000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 6077000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 286000000.00
PHM7.DE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1121000000.00
PHM7.DE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -3400000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Retained Earnings: 35516000000.00
PHM7.DE cash_flow (annual, 2024-12-31) — Sale Of Business: 2353000000.00
PHM7.DE cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
PHM7.DE income_statement (annual, 2024-12-31) — Selling General And Administration: 2737000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Share Issued: 2805961317.00
PHM7.DE cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
PHM7.DE cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
PHM7.DE cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
PHM7.DE cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
PHM7.DE income_statement (annual, 2024-12-31) — Special Income Charges: 2311000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Stockholders Equity: -2238000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Tangible Book Value: -22156000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 405076438.72
PHM7.DE income_statement (annual, 2024-12-31) — Tax Provision: 2394000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.18
PHM7.DE balance_sheet (annual, 2024-12-31) — Taxes Receivable: 93000000.00
PHM7.DE balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 93000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Total Assets: 35177000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Total Capitalization: 21161000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Total Debt: 24926000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -2188000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Total Expenses: 8814000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 37365000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 30664000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 28584000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 11241000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Total Unusual Items: 2311000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 2311000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 1115309450.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Treasury Stock: 42194000000.00
PHM7.DE cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Work In Process: 21000000.00
PHM7.DE balance_sheet (annual, 2024-12-31) — Working Capital: -4268000000.00
PHM7.DE income_statement (annual, 2024-12-31) — Write Off: 389000000.00
PHM7.DE income_statement (quarterly, 2024-12-31) — Write Off: 35000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — +Operating Expense: 588000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — +Total Revenue: 4519000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 550000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 258000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2953000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 5883000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 873000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 8105000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1685557574.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Basic EPS: 0.64
PHM7.DE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3158000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -38000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -38000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 935000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4726000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4726000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -1730000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1085000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -43000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 2720000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -136000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 678000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Change In Inventory: -18000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 263000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Change In Payable: -136000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 542000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Change In Receivables: -80000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 707000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1592000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Common Stock: 935000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -1730000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -3510000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -326000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1270000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 5747000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Current Assets: 6080000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Current Debt: 2631000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2631000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 10655000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 26000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Deferred Tax: 26000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 71000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 71000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1690000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.63
PHM7.DE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1072000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1727000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — EBIT: 1945000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — EBITDA: 2016000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 143000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -143000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 1068000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — End Cash Position: 4750000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Excise Taxes: 740000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1085000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Finished Goods: 310000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 2682000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 25000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2691000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Goodwill: 6072000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 19008000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4561000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Gross Profit: 3249000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 873000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Interest Expense: 262000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 262000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Inventory: 1062000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 22549000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -43000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 8105000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 8105000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 997000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 23428000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 23428000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 997000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 50000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -326000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Net Debt: 21333000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Net Income: 1077000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1072000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1077000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1077000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1077000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1077000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1077000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Net Interest Income: -262000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 997000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 997000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -262000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -26000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -5000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Net PPE: 1608000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -22518000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 3699000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 3699000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1068000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2889000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Normalized Income: 1635720000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 2720000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -118000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Operating Income: 2661000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Operating Revenue: 5276000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1685557574.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 34000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2691000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Other Income Expense: -716000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 12936000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 84000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 959000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 370000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 14000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 5000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Payables: 2277000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 8024000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Pretax Income: 1683000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Raw Materials: 726000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Receivables: 258000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1270000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 71000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -326000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 34868000000.00
PHM7.DE cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 588000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 588000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Share Issued: 2805961317.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Special Income Charges: -873000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -3510000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -22518000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -314280000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Tax Provision: 606000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.36
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Total Assets: 35760000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 19918000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Total Debt: 26059000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -3460000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Total Expenses: 1858000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 39220000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 29680000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 28565000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 1788000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Total Unusual Items: -873000000.00
PHM7.DE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -873000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 1120403743.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 42505000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Work In Process: 26000000.00
PHM7.DE balance_sheet (quarterly, 2025-03-31) — Working Capital: -4575000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — +Operating Expense: 619000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — +Total Revenue: 5290000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 569000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 241000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2920000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 5895000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: -4000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 8143000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1680946062.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Basic EPS: 1.41
PHM7.DE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 4750000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -32000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -32000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 935000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1287000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1287000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -1724000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3608000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -36000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 205000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 13000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -1934000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Change In Inventory: 45000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -485000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Change In Payable: 13000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -1921000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Change In Receivables: 18000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -2343000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -3439000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Common Stock: 935000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -1724000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -3256000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -274000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1440000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 3427000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Current Assets: 2632000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Current Debt: 1069000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1069000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 6788000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 7000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Deferred Tax: 7000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 71000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 71000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1684000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.41
PHM7.DE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2371000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 1723000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — EBIT: 3393000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — EBITDA: 3464000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 148000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -148000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 1068000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — End Cash Position: 1311000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Excise Taxes: 812000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -3608000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Finished Goods: 320000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 173000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 0.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2831000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Goodwill: 6072000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 18972000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4530000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Gross Profit: 3850000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Interest Expense: 275000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 275000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Inventory: 1016000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 21464000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -36000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 8143000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 8143000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 23651000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 23651000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1607000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 50000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -274000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Net Debt: 23433000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Net Income: 2378000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2371000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2378000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2378000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2378000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2378000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2378000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Net Interest Income: -275000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1607000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1607000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -275000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -3000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -4000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Net PPE: 1610000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -22228000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3661000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 3661000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 1068000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3465000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Normalized Income: 2378763000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 205000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -148000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Operating Income: 3231000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Operating Revenue: 6110000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1680946062.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 88000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -2831000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Other Income Expense: 162000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 12900000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 63000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 975000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 370000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 15000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 7000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Payables: 2292000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5719000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Pretax Income: 3118000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Raw Materials: 675000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Receivables: 241000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1440000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 71000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1607000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -274000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 35525000000.00
PHM7.DE cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 619000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 619000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Share Issued: 2805961317.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Special Income Charges: -1000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -3256000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -22228000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -237000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Tax Provision: 740000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Total Assets: 32332000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 20395000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Total Debt: 24720000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -3206000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Total Expenses: 2059000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 35538000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 29700000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 28750000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 3230000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 1125015255.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 42780000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Work In Process: 21000000.00
PHM7.DE balance_sheet (quarterly, 2025-06-30) — Working Capital: -4156000000.00
PHM7.DE income_statement (quarterly, 2025-06-30) — Write Off: 1000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — +Operating Expense: 580000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — +Total Revenue: 5251000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 662000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 249000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -2930000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 5906000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: -5000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 8385000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1311000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -54000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -54000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 935000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 3472000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3472000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -1721000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -849000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -60000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 3094000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 93000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 789000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Change In Inventory: -49000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -230000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Change In Payable: 93000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 882000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Change In Receivables: -10000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 593000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 2185000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Common Stock: 935000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -1721000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -2646000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -112000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1439000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4268000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Current Assets: 5119000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Current Debt: 1569000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1569000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 8286000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 64000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Deferred Tax: 64000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 70000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 70000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2369000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 0.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 1787000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — EBIT: 3353000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — EBITDA: 3423000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 107000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -107000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 1064000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — End Cash Position: 3496000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Excise Taxes: 821000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -849000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Finished Goods: 336000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 3040000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 0.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2709000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Goodwill: 6072000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 18938000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4547000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Gross Profit: 3812000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Interest Expense: 278000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 278000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Inventory: 1065000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 23055000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -60000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 8385000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 8385000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 995000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 24132000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 24132000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 995000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Minority Interest: 50000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -112000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Net Debt: 22229000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Net Income: 2375000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2369000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2375000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2375000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2375000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2375000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2375000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Net Interest Income: -278000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 995000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 995000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -278000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -11000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -6000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Net PPE: 1617000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -21584000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3462000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3462000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 1064000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 3425000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Normalized Income: 2376544000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 3094000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -107000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Operating Income: 3232000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Operating Revenue: 6076000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1679151695.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 333000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2709000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Other Income Expense: 121000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 12866000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 104000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 949000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 660000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 16000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 6000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Payables: 2449000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 6717000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Pretax Income: 3075000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Raw Materials: 710000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Receivables: 249000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1439000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 70000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -112000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 36115000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 580000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 580000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Share Issued: 2805961317.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Special Income Charges: -2000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -2646000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -21584000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -456000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Tax Provision: 700000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Total Assets: 35008000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 21486000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Total Debt: 25701000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -2596000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Total Expenses: 2019000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 37604000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 29889000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 29318000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 3230000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 1126809622.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 42893000000.00
PHM7.DE cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Work In Process: 19000000.00
PHM7.DE balance_sheet (quarterly, 2025-09-30) — Working Capital: -3167000000.00
PHM7.DE income_statement (quarterly, 2025-09-30) — Write Off: 2000000.00
PHM7.DE income_statement (annual, 2025-12-31) — +Operating Expense: 2507000000.00
PHM7.DE income_statement (quarterly, 2025-12-31) — +Operating Expense: 720000000.00
PHM7.DE income_statement (annual, 2025-12-31) — +Total Revenue: 20139000000.00
PHM7.DE income_statement (quarterly, 2025-12-31) — +Total Revenue: 5079000000.00
PHM7.DE balance_sheet (annual, 2025-12-31) — Accounts Payable: 750000000.00
PHM7.DE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 750000000.00
PHM7.DE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 263000000.00
PHM7.DE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 263000000.00
PHM7.DE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -2962000000.00
PHM7.DE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2962000000.00
PHM7.DE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 5921000000.00
PHM7.DE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 5921000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 132000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 132000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 2118000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1254000000.00
PHM7.DE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 8617000000.00
PHM7.DE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 8617000000.00
PHM7.DE income_statement (annual, 2025-12-31) — Basic Average Shares: 1681310680.00
PHM7.DE income_statement (annual, 2025-12-31) — Basic EPS: 4.12
PHM7.DE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3158000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 3496000000.00
PHM7.DE balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 1574000000.00
PHM7.DE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 1574000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Capital Expenditure: -216000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -92000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -216000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -92000000.00
PHM7.DE balance_sheet (annual, 2025-12-31) — Capital Stock: 935000000.00
PHM7.DE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 935000000.00
PHM7.DE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 4474000000.00
PHM7.DE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 4474000000.00
PHM7.DE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4474000000.00
PHM7.DE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4474000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -6960000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1785000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -7615000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2073000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -341000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -202000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 9290000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3271000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Change In Account Payable: 34000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 64000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -176000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 291000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Change In Inventory: -27000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Change In Inventory: -5000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 331000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 783000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Change In Payable: 34000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Change In Payable: 64000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -142000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 355000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Change In Receivables: -86000000.00
PHM7.DE cash_flow (quarterly, 2025-12-31) — Change In Receivables: -14000000.00
PHM7.DE cash_flow (annual, 2025-12-31) — Change In Working Capital: 76000000.00